LONDON, UK / ACCESSWIRE / December 19, 2017 / Active-Investors free earnings report on LHC Group, Inc. (NASDAQ: LHCG) has freshly been issued to its members, and you can also sign up to view this report at www.active-investors.com/registration-sg/?symbol=LHCG. LHC Group posted its third quarter fiscal 2017 (Q3 FY17) results on November 06, 2017. The leading provider of post-acute care services' organic growth of Home Health segment advanced 10.30% in the reported quarter. Register today and get free access to our complimentary member's area where many more reports are available:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, LHC Group most recent news is on our radar and we have decided to include it on our blog post. Today's free coverage is available at:

www.active-investors.com/registration-sg/?symbol=LHCG

Earnings Highlights and Summary

During the third quarter of fiscal 2017 (Q3 FY17), LHC's revenues reflected growth of 18.23% to $272.88 million compared to $230.80 million in Q3 FY16. Revenue numbers topped analysts' estimates of $264.10 million.

LHC posted a gross profit of $100.02 million in Q3 FY17 compared to $89.97 million in Q3 FY16, increasing by 11.17%. The Company had general and administrative expenses (G&A) of $75.67 million in Q3 FY17 compared to $67.00 million in Q3 FY16, advancing 12.94% on a y-o-y basis.

LHC's operating income was $21.33 million in Q3 FY17 compared to $19.55 million in Q3 FY16, reflecting growth of 9.11% on a y-o-y basis. The Company had total organic growth of 6.20% in Home Health segment's admission section. During the nine months ending September 30, 2017, LHC acquired 35 home health, hospice, or community-based locations, and six long-term acute care hospital operations which constituted of $108.00 million of the Company's revenue.

LHC's net income was $12.89 million in the reported quarter compared to $12.17 million in Q3 FY16, increasing by 5.91%. The Company's diluted earnings (EPS) advanced 12.96% to $0.61 per share in Q3 FY17 compared to $0.54 in Q3 FY16. Earnings, adjusted for non-recurring costs, were $0.64 per share in the reported quarter, exceeding analysts' estimates of $0.60 per share.

LHC Group's Segment Details

LHC has four business segments namely: (i) Home Health Services; (ii) Hospital Services; (iii) Community-based Services; and (iv) Facility-based Services.

The Home Health Services segment's revenues were $198.98 million in Q3 FY17 compared to $167.53 million in Q3 FY16, increasing by 18.77% on a y-o-y basis. The operating income of this segment reflected growth of 13.26% to $17.11 million in the reported quarter compared to $15.11 million in Q3 FY16.

Hospital Services segment's revenues were $41.29 million in Q3 FY17 compared to $35.32 million in Q3 FY16, reflecting growth of 16.90% on a y-o-y basis. The operating income of this segment was $2.34 million in the reported quarter compared to $3.79 million, declining 38.19%.

Community-based Services segment's revenues were $12.15 million in Q3 FY17 compared to $11.79 million in Q3 FY16, increasing by 3.00%. The operating income of this segment surged 215.83% to $0.76 million in the reported quarter compared to $0.24 million in Q3 FY16.

Facility-based Services segment's revenues were $20.46 million in Q3 FY17 compared to $16.15 million in Q3 FY16, advancing 26.64% on a y-o-y basis. The operating income of this segment was $1.12 million in Q3 FY17 compared to $0.41 million in Q3 FY16, surging 170.94% on a y-o-y basis.

Cash Matters

LHC had cash and cash equivalents of $16.92 million as on September 30, 2017, compared to $16.52 million as on September 30, 2016. The Company had cash inflow from operating activities of $61.70 million in Q3 FY17 compared to $57.84 million in Q3 FY16.

Outlook

In fiscal 2018, LHC expects earnings to be in the range of $2.35 per share to $2.40 per share and revenues in the band of $1.05 billion to $1.06 billion.

Stock Performance Snapshot

December 18, 2017 - At Monday's closing bell, LHC Group's stock declined 2.68%, ending the trading session at $60.20.

Volume traded for the day: 385.05 thousand shares, which was above the 3-month average volume of 217.18 thousand shares.

Stock performance in the last twelve-month period ? up 36.69%; and year-to-date ? up 31.73%

After yesterday's close, LHC Group's market cap was at $1.08 billion.

Price to Earnings (P/E) ratio was at 25.95.

The stock is part of the Healthcare sector, categorized under the Home Health Care industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors